Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naive Subjects in Hunan Province, China

被引:13
|
作者
Zou Xiaobai [1 ]
Xi, Chen [1 ]
Tian, Hongping [2 ]
Williams, Ann B. [3 ]
Wang, Honghong [4 ]
He, Jianmei [1 ]
Zhen, Jun [1 ]
Chiarella, Jennifer [5 ]
Blake, Lisebeth A. [6 ]
Turenchalk, Gregory [6 ]
Kozal, Michael J. [5 ]
机构
[1] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China
[2] Yale China Assoc, New Haven, CT USA
[3] UCLA Sch Nursing, Los Angeles, CA USA
[4] Cent S Univ, Changsha, Hunan, Peoples R China
[5] Yale Univ, Sch Med, New Haven, CT USA
[6] 454 Life Sci, Branford, CT USA
来源
PLOS ONE | 2014年 / 9卷 / 06期
关键词
REVERSE-TRANSCRIPTASE INHIBITORS; MINORITY POPULATIONS; HIV-1; VARIANTS; THERAPY; FAILURE; GENOME;
D O I
10.1371/journal.pone.0098740
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There are few data on the prevalence of WHO transmitted drug resistance mutations (TDRs) that could affect treatment responses to first line antiretroviral therapy (ART) in Hunan Province, China. Objective: Determine the prevalence of WHO NRTI/NNRTI/PI TDRs in ART-naive subjects in Hunan Province by deep sequencing. Methods: ART-naive subjects diagnosed in Hunan between 2010-2011 were evaluated by deep sequencing for low-frequency HIV variants possessing WHO TDRs to 1% levels. Mutations were scored using the HIVdb.stanford.edu algorithm to infer drug susceptibility. Results: Deep sequencing was performed on samples from 90 ART-naive subjects; 83.3% were AE subtype. All subjects had advanced disease (average CD4 count 134 cells/mm(3)). Overall 25.6%(23/90) of subjects had HIV with major WHO NRTI/NNRTI TDRs by deep sequencing at a variant frequency level >= 1%; 16.7%(15/90) had NRTI TDR and 12.2%(11/90) had a major NNRTI TDR. The majority of NRTI/NNRTI mutations were identified at variant levels <5%. Mutations were analyzed by HIVdb.stanford.edu and 7.8% of subjects had variants with high-level nevirapine resistance; 4.4% had high-level NRTI resistance. Deep sequencing identified 24(27.6%) subjects with variants possessing either a PI TDR or hivdb.stanford.edu PI mutation (algorithm value >= 15). 17(19.5%) had PI TDRs at levels >1%. Conclusions: ART-naive subjects from Hunan Province China infected predominantly with subtype AE frequently possessed HIV variants with WHO NRTI/NNRTI TDRs by deep sequencing that would affect the first line ART used in the region. Specific mutations conferring nevirapine high-level resistance were identified in 7.8% of subjects. The majority of TDRs detected were at variant levels <5% likely due to subjects having advanced chronic disease at the time of testing. PI TDRs were identified frequently, but were found in isolation and at low variant frequency. As PI/r use is infrequent in Hunan, the existence of PI mutations likely represent AE subtype natural polymorphism at low variant level frequency.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naive Subjects in the CASTLE Study
    Lataillade, Max
    Chiarella, Jennifer
    Yang, Rong
    Schnittman, Steven
    Wirtz, Victoria
    Uy, Jonathan
    Seekins, Daniel
    Krystal, Mark
    Mancini, Marco
    McGrath, Donnie
    Simen, Birgitte
    Egholm, Michael
    Kozal, Michael
    PLOS ONE, 2010, 5 (06):
  • [2] Antiretroviral drug resistance mutations in antiretroviral-naive prisoners
    Stone, DR
    Corcoran, C
    Wurcel, A
    McGovern, B
    Quirk, J
    Brewer, A
    Sutton, L
    D'Aquila, RT
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) : 883 - 886
  • [3] Differences in prevalence of transmitted drug resistance mutations between acutely and chronically HIV-infected, antiretroviral-naive patients
    Yanik, E. L.
    Napravnik, S.
    Hurt, C. B.
    Dennis, A.
    Kuruc, J. D.
    Eron, J. J.
    ANTIVIRAL THERAPY, 2011, 16 : A161 - A161
  • [4] Antiretroviral Drug Resistance Mutations in Antiretroviral-Naive Patients from Senegal
    Diop-Ndiaye, Halimatou
    Toure-Kane, Coumba
    Leye, Nafissatou
    Ngom-Gueye, Ndeye Fatou
    Montavon, Celine
    Peeters, Martine
    Mboup, Souleymane
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : 1133 - 1138
  • [5] HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China
    Chen, Xi
    Zou, Xiaobai
    He, Jianmei
    Zheng, Jun
    Chiarella, Jennifer
    Kozal, Michael J.
    PLOS ONE, 2016, 11 (02):
  • [6] Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China
    Zou, Xiaobai
    He, Jianmei
    Zheng, Jun
    Malmgren, Roberta
    Li, Weisi
    Wei, Xiuqing
    Zhang, Guoqiang
    Chen, Xi
    VIROLOGY JOURNAL, 2020, 17 (01)
  • [7] Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China
    Xiaobai Zou
    Jianmei He
    Jun Zheng
    Roberta Malmgren
    Weisi Li
    Xiuqing Wei
    Guoqiang Zhang
    Xi Chen
    Virology Journal, 17
  • [8] HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey
    Sayan, Murat
    Sargin, Fatma
    Inan, Dilara
    Sevgi, Dilek Y.
    Celikbas, Aysel K.
    Yasar, Kadriye
    Kaptan, Figen
    Kutlu, Selda
    Fisgin, Nuriye T.
    Inci, Ayse
    Ceran, Nurgul
    Karaoglan, Ilkay
    Cagatay, Atahan
    Celen, Mustafa K.
    Koruk, Suda T.
    Ceylan, Bahadir
    Yildirmak, Taner
    Akalin, Halis
    Korten, Volkan
    Willke, Ayse
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (01) : 26 - 31
  • [9] PI mutations and polymorphisms in HIV subtype AE by deep sequencing in ART-naive subjects from Hunan Province, China
    Zou, X.
    Chen, X.
    Tian, H.
    Williams, A. B.
    Wang, H.
    He, J.
    Zhen, J.
    Chiarella, J.
    Kozal, M. J.
    ANTIVIRAL THERAPY, 2014, 19 : A100 - A100
  • [10] Transmitted Drug Resistance Mutations in Antiretroviral-Naive Injection Drug Users with Chronic HIV-1 Infection in Iran
    Memarnejadian, Arash
    Menbari, Shahoo
    Mansouri, Seyed Ali
    Sadeghi, Leila
    Vahabpour, Rouhollah
    Aghasadeghi, Mohammad Reza
    Mostafavi, Ehsan
    Abdi, Mohammad
    PLOS ONE, 2015, 10 (05):